Key result
Percutaneous aortic balloon valvuloplasty resulted in actuarial survival of 75% at 6 months and 63% at 12 months, with 85% of survivors experiencing improved congestive heart failure symptoms.
Population
88 patients with severe symptomatic calcific aortic stenosis, mean age 80 +/- 8 years
Design
Cohort
Follow-up
average 7.8 months in survivors
Authors
Loading...
May support palliative symptom relief in high-risk aortic stenosis; leaves open comparative survival benefit versus alternatives.
Observational (n=88)
Percutaneous aortic balloon valvuloplasty provides good symptomatic relief but is associated with high continued mortality, making it suitable primarily as a palliative approach for high-risk patients.
David R. Holmes (1989) conducted an observational in severe symptomatic calcific aortic stenosis (n=88). Percutaneous aortic balloon valvuloplasty was evaluated on Actuarial survival at 12 months. Percutaneous aortic balloon valvuloplasty resulted in actuarial survival of 75% at 6 months and 63% at 12 months, with 85% of survivors experiencing improved congestive heart failure symptoms.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: